Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 29,250 shares at $7.76 ($224K) on 2019-05-13, disclosed to the SEC on 2019-05-13.
Open-market sale of $224k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.63 | 9,750 | $74K | 33.1% |
| 2 | $7.63 | 9,750 | $74K | 33.1% |
| 3 | $7.76 | 9,750 | $76K | 33.7% |
| Total | $7.67 avg | 29,250 | $224K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |
| BCRX | SELL | 2019-04-08 | $66K | — | Filing → |